GlassScriptPhysician profile
Amrit Thakur
NPI 1134649205
$5,176.19
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $388 · 2022: $1,355 · 2023: $2,197 · 2024: $1,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,359 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,358.74 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $569.28 | 2021-2024 | Watchman Access System, Watchman Flx, Wolverine Coronary Cutting Balloon |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $549.78 | 2021-2024 | Lifevest |
| Zoll Circulation INC | $546.91 | 2022-2024 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Abiomed | $481.70 | 2022-2023 | Impella |
| Novartis Pharmaceuticals Corporation | $458.38 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $414.94 | 2023-2024 | Farxiga, Wainua, Brilinta |
| Janssen Pharmaceuticals, INC | $347.47 | 2021-2024 | Xarelto |
| Shockwave Medical, INC | $297.51 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.30 | 2023-2024 | Jardiance |
| Heartflow, INC. | $228.16 | 2024 | |
| Medtronic, INC. | $179.22 | 2022-2023 | Corevalve Evolut R |
| Amgen INC. | $177.37 | 2021-2024 | Repatha |
| Abbott Laboratories | $149.43 | 2024 | Amplatzer Talisman |
| Bayer Healthcare Pharmaceuticals INC. | $124.98 | 2022 | |
| Pfizer INC. | $124.97 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $93.33 | 2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $92.53 | 2023 | Camzyos |
| Chiesi USA, INC. | $67.44 | 2023-2024 | Kengreal |
| Penumbra, INC. | $16.49 | 2023 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amrit Thakur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.